Stay updated on Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial page.

Latest updates to the Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial page
- Check3 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check10 days agoChange DetectedRevision: v3.4.3 was applied, replacing the previous v3.4.2.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedAdded Revision: v3.4.2; removed the funding lapse notice and the previous Revision: v3.4.1. These changes pertain to site maintenance banners and do not affect study details.SummaryDifference0.4%

- Check46 days agoChange DetectedA government funding lapse notice was added to the top of the page and the revision label changed from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check53 days agoChange DetectedUI updates include a Show glossary toggle and new study-record dates such as Results First Posted, Last Update Submitted that Met QC Criteria, and Last Update Posted, along with a revision notice (v3.4.0). Older labels and data points (Results First Posted (Estimated), Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data) were removed or renamed.SummaryDifference0.3%

- Check67 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial page.